Related Experiment Video
Updated: Jul 27, 2026
10:17
The Tail Suspension Test
Published on: January 29, 2012
Clotting abnormality in lithium treated rats.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|January 1, 1983
Summary
Lithium administration significantly enhanced blood clotting in rats. This suggests lithium may influence the prothrombin to thrombin conversion, impacting coagulation. Further research is needed to assess clinical relevance.
Area of Science:
- Biochemistry
- Hematology
- Pharmacology
Background:
- Blood clotting is a complex physiological process essential for hemostasis.
- Lithium is a medication with known systemic effects, but its impact on coagulation is not fully understood.
Purpose of the Study:
- To investigate the effect of lithium administration on blood clotting in a rat model.
- To explore the potential mechanism by which lithium influences coagulation.
Main Methods:
- Rats were administered lithium through diet or parenteral routes.
- Whole blood clotting time was assessed.
- The prothrombin consumption index was evaluated to infer the mechanism of action.
Main Results:
- Lithium treatment markedly influenced blood clotting.
- Significant enhancement of whole blood clotting was observed in lithium-treated rats.
- Prothrombin consumption index data suggest lithium affects prothrombin to thrombin conversion.
Conclusions:
- Lithium administration significantly alters blood clotting parameters in rats.
- The findings indicate a potential role for lithium in modulating the coagulation cascade, specifically the conversion of prothrombin to thrombin.
- The clinical significance of these hematological effects warrants further investigation.
